• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌筛查:对照试验的系统评价与荟萃分析

Screening for lung cancer: a systematic review and meta-analysis of controlled trials.

作者信息

Manser R L, Irving L B, Byrnes G, Abramson M J, Stone C A, Campbell D A

机构信息

Clinical Epidemiology and Health Service Evaluation Unit, Ground Floor, Charles Connibere Building, Royal Melbourne Hospital, Grattan Street, Parkville 3050, Victoria, Australia.

出版信息

Thorax. 2003 Sep;58(9):784-9. doi: 10.1136/thorax.58.9.784.

DOI:10.1136/thorax.58.9.784
PMID:12947138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1746815/
Abstract

BACKGROUND

Lung cancer is a substantial public health problem in western countries. Previous studies have examined different screening strategies for lung cancer but there have been no published systematic reviews.

METHODS

A systematic review of controlled trials was conducted to determine whether screening for lung cancer using regular sputum examinations or chest radiography or computed tomography (CT) reduces lung cancer mortality. The primary outcome was lung cancer mortality; secondary outcomes were lung cancer survival and all cause mortality.

RESULTS

One non-randomised controlled trial and six randomised controlled trials with a total of 245 610 subjects were included in the review. In all studies the control group received some type of screening. More frequent screening with chest radiography was associated with an 11% relative increase in mortality from lung cancer compared with less frequent screening (RR 1.11, 95% CI 1.00 to 1.23). A non-statistically significant trend to reduced mortality from lung cancer was observed when screening with chest radiography and sputum cytological examination was compared with chest radiography alone (RR 0.88, 95% CI 0.74 to 1.03). Several of the included studies had potential methodological weaknesses. Controlled studies of spiral CT scanning have not been reported.

CONCLUSIONS

The current evidence does not support screening for lung cancer with chest radiography or sputum cytological examination. Frequent chest radiography might be harmful. Further methodologically rigorous trials are required before any new screening methods are introduced into clinical practice.

摘要

背景

肺癌在西方国家是一个重大的公共卫生问题。以往的研究探讨了不同的肺癌筛查策略,但尚无已发表的系统评价。

方法

进行了一项对照试验的系统评价,以确定使用定期痰检、胸部X线摄影或计算机断层扫描(CT)筛查肺癌是否能降低肺癌死亡率。主要结局是肺癌死亡率;次要结局是肺癌生存率和全因死亡率。

结果

该评价纳入了1项非随机对照试验和6项随机对照试验,共245610名受试者。在所有研究中,对照组都接受了某种类型的筛查。与筛查频率较低相比,更频繁的胸部X线摄影筛查与肺癌死亡率相对增加11%相关(风险比1.11,95%可信区间1.00至1.23)。当将胸部X线摄影和痰细胞学检查与单纯胸部X线摄影进行比较时,观察到肺癌死亡率有降低的趋势,但无统计学意义(风险比0.88,95%可信区间0.74至1.03)。纳入的几项研究存在潜在的方法学缺陷。尚未报道螺旋CT扫描的对照研究。

结论

目前的证据不支持用胸部X线摄影或痰细胞学检查筛查肺癌。频繁的胸部X线摄影可能有害。在将任何新的筛查方法引入临床实践之前,需要进行进一步方法学严谨的试验。

相似文献

1
Screening for lung cancer: a systematic review and meta-analysis of controlled trials.肺癌筛查:对照试验的系统评价与荟萃分析
Thorax. 2003 Sep;58(9):784-9. doi: 10.1136/thorax.58.9.784.
2
Screening for lung cancer.肺癌筛查
Cochrane Database Syst Rev. 2004(1):CD001991. doi: 10.1002/14651858.CD001991.pub2.
3
Screening for lung cancer.肺癌筛查
Cochrane Database Syst Rev. 2001(3):CD001991. doi: 10.1002/14651858.CD001991.
4
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.低剂量计算机断层扫描(LDCT)筛查对肺癌相关死亡率的影响。
Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews.计算机断层扫描筛查肺癌的临床有效性和成本效益:系统评价
Health Technol Assess. 2006 Jan;10(3):iii-iv, ix-x, 1-90. doi: 10.3310/hta10030.
7
Inhaled mannitol for cystic fibrosis.吸入用甘露醇治疗囊性纤维化。
Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3.
8
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.
9
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
10
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.

引用本文的文献

1
A Novel Deep Learning-Based (3D U-Net Model) Automated Pulmonary Nodule Detection Tool for CT Imaging.一种基于深度学习的新型(3D U-Net模型)CT成像自动肺结节检测工具。
Curr Oncol. 2025 Feb 8;32(2):95. doi: 10.3390/curroncol32020095.
2
Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.将戒烟纳入肺癌筛查的临床影响和成本效益:微观模拟模型
CMAJ Open. 2020 Sep 22;8(3):E585-E592. doi: 10.9778/cmajo.20190134. Print 2020 Jul-Sep.
3
Measuring quality of life in Duchenne muscular dystrophy: a systematic review of the content and structural validity of commonly used instruments.测量杜氏肌营养不良症患者的生活质量:常用工具的内容和结构有效性的系统评价。
Health Qual Life Outcomes. 2020 Aug 3;18(1):263. doi: 10.1186/s12955-020-01511-z.
4
Role of chest radiographs in early lung cancer detection.胸部X光片在早期肺癌检测中的作用。
Transl Lung Cancer Res. 2020 Jun;9(3):522-531. doi: 10.21037/tlcr.2020.04.02.
5
Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients.评估循环微小RNA谱在有症状患者肺癌检测中的应用
JAMA Oncol. 2020 May 1;6(5):714-723. doi: 10.1001/jamaoncol.2020.0001.
6
Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward.发展中国家肺癌筛查的可行性:挑战、机遇与未来方向。
Transl Lung Cancer Res. 2019 May;8(Suppl 1):S106-S121. doi: 10.21037/tlcr.2019.03.03.
7
A multi-parameterized artificial neural network for lung cancer risk prediction.用于肺癌风险预测的多参数人工神经网络。
PLoS One. 2018 Oct 24;13(10):e0205264. doi: 10.1371/journal.pone.0205264. eCollection 2018.
8
[Lung Nodules Assessment--Analysis of Four Guidelines].[肺结节评估——四项指南分析]
Zhongguo Fei Ai Za Zhi. 2017 Jul 20;20(7):490-498. doi: 10.3779/j.issn.1009-3419.2017.07.08.
9
Reflection of illness and strategies for handling advanced lung cancer - a qualitative analysis in patients and their relatives.晚期肺癌患者及其亲属对疾病的认知与应对策略——一项质性分析
BMC Health Serv Res. 2017 Mar 2;17(1):173. doi: 10.1186/s12913-017-2110-x.
10
Lung cancer in Basrah, Iraq during 2005-2012. Incidence and time trend.2005 - 2012年伊拉克巴士拉的肺癌。发病率及时间趋势。
Saudi Med J. 2016 Nov;37(11):1214-1219. doi: 10.15537/smj.2016.11.16269.

本文引用的文献

1
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.正电子发射断层扫描与计算机断层扫描相结合用于非小细胞肺癌分期
N Engl J Med. 2003 Jun 19;348(25):2500-7. doi: 10.1056/NEJMoa022136.
2
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.《CONSORT 声明:改进平行组随机试验报告质量的修订建议》
Lancet. 2001 Apr 14;357(9263):1191-4.
3
Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe.北美、澳大利亚、新西兰及欧洲肺癌组织学亚型的发病率及预后趋势。
Lung Cancer. 2001 Feb-Mar;31(2-3):123-37. doi: 10.1016/s0169-5002(00)00197-5.
4
Considerations in developing successful, population-based molecular screening and prevention of lung cancer.开展成功的基于人群的肺癌分子筛查与预防的考量因素。
Cancer. 2000 Dec 1;89(11 Suppl):2465-7. doi: 10.1002/1097-0142(20001201)89:11+<2465::aid-cncr24>3.3.co;2-y.
5
Extent of surgery and survival in early lung carcinoma: implications for overdiagnosis in stage IA nonsmall cell lung carcinoma.早期肺癌的手术范围与生存情况:对IA期非小细胞肺癌过度诊断的影响
Cancer. 2000 Dec 1;89(11 Suppl):2432-7. doi: 10.1002/1097-0142(20001201)89:11+<2432::aid-cncr17>3.3.co;2-1.
6
Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment.捷克肺癌筛查研究:自入组以来长达15年的肺癌死亡病例试验后随访。
Cancer. 2000 Dec 1;89(11 Suppl):2363-8. doi: 10.1002/1097-0142(20001201)89:11+<2363::aid-cncr9>3.3.co;2-n.
7
Screening for lung cancer.肺癌筛查
N Engl J Med. 2000 Nov 30;343(22):1627-33. doi: 10.1056/NEJM200011303432208.
8
Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up.梅奥肺癌项目中的肺癌死亡率:延长随访的影响
J Natl Cancer Inst. 2000 Aug 16;92(16):1308-16. doi: 10.1093/jnci/92.16.1308.
9
Overdiagnosis: An underrecognized cause of confusion and harm in cancer screening.
J Natl Cancer Inst. 2000 Aug 16;92(16):1280-2. doi: 10.1093/jnci/92.16.1280.
10
Is screening for breast cancer with mammography justifiable?用乳房X线摄影术筛查乳腺癌是否合理?
Lancet. 2000 Jan 8;355(9198):129-34. doi: 10.1016/S0140-6736(99)06065-1.